Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Cuscuta reflexa leaves extract may help lower blood sugar and improve diabetes symptoms.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Upadacitinib improved multiple immune-related conditions in one patient.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Adding a second method to PROTACs could improve cancer treatment.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Clofazimine may be effective for treating ashy dermatosis.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Engineered bacteria can deliver antioxidants to protect skin.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.